C. Jimmy Lin

C. Jimmy Lin, MD, PhD, MHS, serves as the Chief Scientific Officer at Freenome, leading efforts to develop noninvasive blood tests for early-stage cancer detection through advanced machine learning and genomic science. Additionally, C. Jimmy Lin holds the position of Venture Partner at SparkLabs Global Ventures and is the Founder and Chief Executive Officer of Rare Genomics Institute, which supports personalized research for patients with orphan diseases. Previous roles include Chief Scientific Officer for Natera's oncology division, advisory panel member at the Patient-Centered Outcomes Research Institute, and TED Fellow. Educational credentials comprise an MD/PhD in Cellular and Molecular Medicine from The Johns Hopkins University, a Master's in Health Sciences from the Johns Hopkins Bloomberg School of Public Health, and a degree in Cognitive Science from Yale University, along with ongoing studies in Theology.